Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
almitrine (1 trial)
clarithromycin (biaxin) (1 trial)
emtricitabine (emtriva) (1 trial)
esomeprazole (nexium) (1 trial)
hydrocortisone (solu-cortef) (1 trial)
metronidazole (flagyl) (1 trial)
prednisone (meticorten) (1 trial)
procaine benzylpenicillin (novocaine) (1 trial)
tenofovir (viread) (1 trial)
tetracycline (tetrex) (1 trial)
cetuximab (erbitux) (1 trial)
Carcinoma (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Pneumonia (Phase 3)
Respiratory Insufficiency (Phase 3)
Skin Diseases (Phase 2)
Trials (4 total)
Trial APIs (11 total)